FAM111B and ovarian carcinoma: Further investigation into pathways demonstrated that FAM111B was linked to the tumor proliferation signature (R = 0.51, P < 0.001), MYC pathway (R = 0.32, P < 0.001), and the EMT (R = 0.20, P < 0.001) in ovarian cancer (Fig. 8D–F).